Ebola disease in DRC
On 1 December 2025, the Democratic Republic of the Congo declared the outbreak of Ebola disease over
On 1 December 2025, The Democratic Republic of the Congo declared the end of an outbreak of Ebola disease (EBOD) in Kasai Province following a 42-day period (two consecutive incubation periods of the virus) without recording any new cases [1].
Since the outbreak was declared on 4 September 2025, a total of 64 cases (53 confirmed and 11 probable), including 45 deaths were reported [1, 2].
The World Health Organization (WHO) and partners provided technical, operational and financial support to the Democratic Republic of the Congo government to contain the outbreak. Surveillance to rapidly identify and respond to any re-emergence is ongoing, including a 90 day period of enhanced surveillance.
The outbreak was the country's 16th since the disease was identified in 1976 [1]. Ebola disease is caused by orthoebolaviruses. There are six species of orthoebolavirus, four of which are known to cause disease in humans [2]. The natural reservoir for the virus is believed to be fruit bats from the Pteropodidae family. Non-human primates are known to have been a source of human infection in some of the previous EBOD outbreaks [3].
Resources
References
-
World Health Organization. Democratic Republic of the Congo declares end of 16th Ebola outbreak. 1 December 2025. [Accessed 9 December 2025]
-
World Health Organization, Democratic Republic of the Congo declares Ebola virus disease outbreak in Kasai Province. 4 September 2025 [Accessed 9 December 2025]
-
UK Health Security Agency. Ebola: overview, history, origins and transmission. Updated 4 September 2025. [Accessed 9 December 2025]
Explore more
Marburg virus disease in Ethiopia
On 26 January 2026, the Ministry of Health of Ethiopia declared the end of the Marburg virus disease outbreak
Updated: 05 February 2026ABTA Destinations to Watch report published
ABTA has launched its Destinations to Watch report for 2026
Updated: 03 February 2026Mefloquine shortage
Shortage of 250mg mefloquine (Lariam) antimalarial tablets in the United Kingdom (UK) until the end of March 2026
Updated: 30 January 2026NaTHNaC Telephone Advice Line for health professionals
Additional advice line sessions are planned, starting in January 2026
Updated: 21 January 2026Country Information updates: Japanese encephalitis vaccine recommendations
NaTHNaC has reviewed and updated the Japanese encephalitis (JE) country-specific information and vaccine recommendations
Updated: 19 January 2026
